Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Commerce Minister Speaks Strongly Against EU Drug Seizures

This article was originally published in PharmAsia News

Executive Summary

Recent seizures of Indian generic drugs bound for other destinations transiting through European ports are one of many attempts to discredit Indian generic drugs, visiting Indian Commerce & Industry Minister Anand Sharma told reporters in Washington on June 18 during a press briefing

You may also be interested in...



Anti-Counterfeiting Trade Agreement Seeks To Exclude Patent Enforcement

When the U.S. and other countries began negotiating the terms of the Anti-Counterfeiting Trade Agreement, the generic industry was worried that it might be used to expand the rights of patent owners

Anti-Counterfeiting Trade Agreement Seeks To Exclude Patent Enforcement

When the U.S. and other countries began negotiating the terms of the Anti-Counterfeiting Trade Agreement, the generic industry was worried that it might be used to expand the rights of patent owners

India And Singapore Create Fast Track For Generics Approval, Lifting Regulatory Process For Some Drugs

NEW DELHI - Indian generic drug manufacturers have made another mark on the international arena by gaining faster and broader market access for their products in Singapore

Related Content

UsernamePublicRestriction

Register

LL1127674

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel